Today, the VP & CAO of Cryolife (NYSE: CRY), Amy Horton, sold shares of CRY for $103.8K.
Following Amy Horton’s last CRY Sell transaction on November 13, 2017, the stock climbed by 6.4%. In addition to Amy Horton, 4 other CRY executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on Cryolife’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $61.95 million and GAAP net loss of $3.82 million. In comparison, last year the company earned revenue of $45.06 million and had a net profit of $2.18 million. Currently, Cryolife has an average volume of 74.64K.
The insider sentiment on Cryolife has been negative according to 69 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Amy Horton’s trades have generated a -36.0% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
CryoLife, Inc. is a medical devices company, which engages in the processing and distribution of implantable human tissues for use in cardiac and vascular surgeries. It operates through the Medical Devices and Preservation Services segments.
